Fgl2 (4H5) Antibody sc-100276 from Santa Cruz Biotechnology, Inc.

Product Specs
ItemFgl2 (4H5) Antibody
CompanySanta Cruz Biotechnology, Inc.
Price $333.00Supplier Page View Company Product Page
Catalog Numbersc-100276
NCBI Gene Aliasesmusfiblp, T49, pT49
Antibody TypePrimary Antibodies
Clone4H5
Quantity100 µg/ml
ApplicationsWB, IP, IF, IHC(P), ELISA
Reactivitymouse, rat, human
Hostmouse
FormatPurified
ClonalityMonoclonal
Conjugate/TagUnconjugated
NCBI Full Gene Namefibrinogen-like protein 2, fibrinogen like 2
TargetFgl2
IsotypeIgG2a

Add to Compare List

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) Serum fibrinogen-like protein 2 is associated with diabetic nephropathy severity and modulates high glucose-induced tubular dysfunction via Akt-FoxO1 signalingRen FailMay 20, 2026Xiao Gang Lu, Hui Jin, Ya Pei Wang, Hong Bin Li, Yin Qin Chengtemperature and incubated overnight at 4 °C with the following primary antibodies: anti-FGL2 (1:500, sc-100276, rabbit monoclonal, Santa Cruz), anti-p-Akt (Ser473) (1:400, ab81283, rabbit monoclonal, Abcam), anti-Akt

(2) Fibrinogen-like protein 2 regulates inflammatory and metabolic reprogramming of airway smooth muscle cells through PI3K/Akt activationFront Med (Lausanne)May 12, 2026Bo Zhao, Yanran Cheserum albumin and then incubated overnight at 4 °C with the following primary antibodies: FGL2 (1:500, sc-100276, mouse monoclonal, Santa Cruz Biotechnology); phosphorylated PI3K (p85, Tyr458; 1:400, ab278545, rabbit

(3) Disruption of FGL2 induces TFEB-dependent lysosomal degradation of PD-L1 and enhances the efficacy of anti-PD1 therapy in hepatocellular carcinomaCell Communication and SignalingFebruary 2, 2026Meiwen Han, Qianting Guan, Fangfei Yan, Ming Wang, Dong Xi, Qin Ningavoid nonspecific binding. Next, membranes were incubated with the following antibodies: FGL2 (1:500) (sc-100276, Santa Cruz Biotechnology), PD-L1 (1:4000) (66248-1-Ig, Proteintech), DDDDK-Tag (1:5000) (AE063, Abclonal),

(4) VSIG4 inhibits proinflammatory macrophage activation by reprogramming mitochondrial pyruvate metabolismNature communicationsNovember 6, 2017Li J, Diao B, Guo S, Huang X, Yang C, Feng Z, Yan W, Ning Q, Zheng L, Chen Y, et al.(pH 6.0) at 120°C for 10 min. Sections were then incubated at 4 °C overnight with anti-mouse FGL2 (#sc-100276, Santa Cruz, 1:100, mouse), anti-Fibrinogen (#ab118533, Abcam, Cambridge, England, 1:1000, Rabbit),

(5) Neuroprotective effects of activated protein C on intrauterine inflammation-induced neonatal white matter injury are associated with the downregulation of fibrinogen-like protein 2/fibroleukin prothrombinase and the inhibition of pro-inflammatory cytokine expressionInternational journal of molecular medicineMay 1, 2015Jin SJ, Liu Y, Deng SH, Liao LH, Lin TL, Ning Q, Luo XP.according to standard protocols or prepared for immunohistochemistry. Mouse anti-fgl2 monoclonal antibody (sc-100276; Santa Cruz Biotechnology, Santa Cruz, CA, USA), rabbit anti-fibrinogen/fibrin polyclonal antibody (ab34269;

(6) The imitation switch ATPase Snf2l is required for superovulation and regulates Fgl2 in differentiating mouse granulosa cellsBiology of reproductionJune 1, 2013Pépin D, Paradis F, Perez-Iratxeta C, Picketts DJ, Vanderhyden BC.

(7) Intrahepatic expression of programmed death-1 and its ligands in patients with HBV-related acute-on-chronic liver failureInflammationFebruary 1, 2013Cao D, Xu H, Guo G, Ruan Z, Fei L, Xie Z, Wu Y, Chen Y.

(8) The intrahepatic expression and distribution of BTLA and its ligand HVEM in patients with HBV-related acute-on-chronic liver failureDiagnostic pathologyOctober 15, 2012Xu H, Cao D, Guo G, Ruan Z, Wu Y, Chen Y.

(9) The characteristic expression of B7-H3 and B7-H4 in liver biopsies from patients with HBV-related acute-on-chronic liver failurePathology internationalOctober 1, 2012Guo G, Cao D, Xu H, Ruan Z, Fei L, Xie Z, Wu Y, Chen Y.

(10) Secretion of sodium and potassium by the parotid gland in essential hypertensionSouthern medical journalApril 1, 1969Young JL Jr, Greene AS, Smith BN.

(11) Von Willebrand factor protects against acute CCl₄-induced hepatotoxicity through phospho-p38 MAPK signaling pathway inhibitionImmunologic researchJanuary 1, 0001"Sun HJ, Chen J, Zhang H, Ni B, van Velkinburgh JC, Liu Y, Wu YZ, Yang X."

Be the First to Write a Review!

Fgl2 (4H5) Antibody

Fgl2 (4H5) Antibody from Santa Cruz Biotechnology, Inc.

Description

Santa Cruz Biotechnology, Inc.

Citations (11)

Reviews

Fgl2 (4H5) Antibody from Santa Cruz Biotechnology, Inc.

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map